Where the math is defensible.
Long-form research on live enterprise decisions. Publication is selective. Every number traces to a named source. No takes without evidence.
Antimicrobial Resistance in Sub-Saharan Africa 2026: Surveillance Gaps and Financing Arithmetic
Sub-Saharan Africa carries the highest per-capita AMR burden on the planet, yet captures the smallest share of surveillance, diagnostics, and stewardship finance. This brief sets out the arithmetic of closing that gap by 2030.
Sub-Saharan Africa carries the world's highest age-standardized mortality from bacterial antimicrobial resistance, with an estimated 1.05 million deaths attributable or associated with resistant infections each year. Yet the region contributes less than 9 percent of records in the WHO GLASS dataset, finances roughly 12 percent of the diag...
GLP-1 Global Supply Chain 2026: From Shortage to Surplus, From Pricing Power to Pushback
Semaglutide and tirzepatide are exiting the FDA shortage list, compounding pharmacies are losing legal cover, and Indian generics are rewriting the affordability curve. The next bottleneck is payer authorization, not vials.
GLP-1 receptor agonists have moved from a manufacturing crisis into a payer crisis in 18 months. Novo Nordisk and Eli Lilly together invested more than 60 billion dollars in capacity through 2024 and 2025, the FDA removed semaglutide and tirzepatide from the formal shortage list in early 2025, and the 503A and 503B compounding gray market...
GLP-1 at the Medicare Bargaining Table: Ozempic, Wegovy, and the 2027 Pricing Reset
Medicare's first negotiated prices took effect January 2026 across ten high-spend drugs. Cohort two, effective 2027, now includes Ozempic. The implications for Novo Nordisk, Eli Lilly, compounding telehealth, and global access stretch from Indianapolis to Indore.
The Inflation Reduction Act's drug price negotiation program moves from theory to invoice. CMS published Maximum Fair Prices for the first ten Part D drugs (Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, NovoLog) effective January 1, 2026, with discounts ranging from 38 to 79 percent off 2023 list (CM...
H5N1 in US Dairy 2024 to 2026: A Slow-Motion Pandemic Stress Test
Two years after the first detection of H5N1 genotype B3.13 in a Texas dairy herd, the outbreak has spread to 17 states, infected at least 70 workers, killed one person, and left the United States one reassortment event away from a pandemic.
On 25 March 2024 the USDA confirmed the first detection of highly pathogenic avian influenza H5N1 in dairy cattle, in a Texas herd presenting with reduced milk production and lethargy. Two years later, the outbreak is the largest mammalian H5N1 event ever recorded. The B3.13 genotype has crossed into 17 states and roughly 1,070 herds, inf...
India Ayushman Bharat at five years: coverage, claims, and the OOP question
PMJAY has issued more than 360 million health cards and authorized over 90 million hospital admissions, yet out-of-pocket spending still funds nearly two of every five rupees of Indian health care. The next phase will be judged less by enrollment than by whether the scheme bends the household cost curve.
Five years after Pradhan Mantri Jan Arogya Yojana (PMJAY) went national, India has built the largest publicly funded health assurance program in the world, covering roughly 550 million people on paper and authorizing claims worth more than 1.4 trillion rupees through early 2026. Coverage and utilization have grown rapidly, but state-level...
Kenya health financing 2026: SHIF rollout, fiscal arithmetic, donor cliff
The Social Health Insurance Fund inherits NHIF's debts and Kenya's universal coverage ambitions just as PEPFAR, Global Fund, and Gavi rewrite the rules of co-financing. The arithmetic is brutal, but tractable.
Kenya replaced the National Hospital Insurance Fund with the Social Health Insurance Fund in October 2024, anchoring universal coverage on a 2.75 percent salary deduction and a means tested contribution for informal workers. Eighteen months later, enrollment has climbed past 22 million principal members, but only a fraction are paying. Pr...
US healthcare private equity rollup at the antitrust inflection: physician practices, hospital chapter 11, and the 2026 refi wall
PE healthcare deal value has settled into the 80 to 100 billion dollar a year band after the 2021 peak, even as Envision and Steward have proven the LBO model can break, and the FTC, DOJ, and a growing list of state attorneys general are now writing rules around physician rollups.
Private equity ownership in US healthcare reached an inflection point between 2023 and 2026. Pitchbook tallied roughly 1,049 PE healthcare deals in 2024 with disclosed value near 115 billion dollars, well below the 2021 peak. KKR backed Envision Healthcare filed for chapter 11 in May 2023, wiping out about 7 billion dollars of equity. Cer...
The US Higher Education Cliff: Demographics, Defaults, and the Tier Bifurcation
The 2008 birth cohort reaches college age in fall 2026, the first full impact of a 15 percent decline in 18 year olds projected through 2039. Layered on top: a botched FAFSA cycle that broke aid processing, a proposed 21 percent endowment tax on the largest funds, and a state revenue share that has fallen from roughly 70 percent of public university revenue in the early 1990s to about 40 percent today. The sector splits into two solvency curves.
US higher education enters the 2026 to 2027 academic year facing the long forecast demographic cliff. The Western Interstate Commission for Higher Education projects the high school graduating class will peak near 3.9 million in 2025 and decline by roughly 13 percent through 2041, with the 18 year old population down 15 percent over the s...
The US K-12 Enrollment Cliff: ESSER Sunset, District Fiscal Stress, and the Sorting of School Systems Through 2026
Public school enrollment peaked in fall 2019 near 50.8 million and is projected at 49.4 million in fall 2024 per NCES, with West and Northeast regions absorbing the bulk of the loss. The Elementary and Secondary School Emergency Relief obligation deadline closed September 30 2024, with final liquidation due March 2026. Birth cohorts are 11 percent below 2007 peak and the 2020 to 2024 fertility decline locks in a deeper trough into the early 2030s. Charter, voucher, and homeschool enrollment have absorbed roughly 1.5 to 2 million students in net flows since 2019. The result is a fiscal sorting event running through district size, regional demographics, and program concentration.
US public K-12 enrollment fell from a fall 2019 peak of approximately 50.8 million to roughly 49.4 million in fall 2024 per NCES projection tables, a structural loss of about 1.4 million students that did not recover with end of pandemic in person learning. Births fell from 3.747 million in 2019 to 3.596 million in 2023 and a CDC provisio...
Medicare Advantage at the Reset: V28 Risk Adjustment, Star Ratings, and Insurer Profit Through 2026
The April 2025 CMS Final Rate Notice locked in a 5.06 percent effective rate change for contract year 2026, the final year of V28 phase in, and the second consecutive cycle in which Humana, UnitedHealth, CVS Aetna, Elevance, Centene, and Cigna issued downward earnings revisions tied to medical loss ratio normalization.
Medicare Advantage covers roughly 54 percent of eligible Medicare beneficiaries in 2025, about 34 million enrollees on a fee for service base of 67 million, but the program is the most stressed health insurance line in the United States. The Centers for Medicare and Medicaid Services published the Calendar Year 2026 Final Rate Notice on A...
US Student Loans After the Pause: SAVE Unwound, Project 2025 Reforms, and the 2026 Repayment Reset
Federal student loans returned to billing in October 2023 after a 3.5 year COVID pause. The 12 month on ramp shielded credit reports through September 2024. Then SAVE was enjoined, then struck down. By Q1 2025, 12.6 percent of borrowers in repayment were 90 plus days delinquent, the worst delinquency print in the history of the New York Fed Household Debt and Credit Report. The 2026 reset is not a return to 2019. It is a rewrite.
The federal student loan portfolio sits at roughly 1.65 trillion dollars across about 43 million borrowers as of Q4 2024, per Federal Student Aid Data Center quarterly reports. Payments resumed in October 2023 after a pause that ran from March 2020 through September 2023, and the Biden Department of Education layered a 12 month on ramp th...